Peifeng Li
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.2%
- Circular RNAs in diseases
- RNA modifications and cancer
- Mitochondrial Function and Pathology
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 78
- RNA modifications and cancer 40
- Mitochondrial Function and Pathology 33
- Cell death mechanisms and regulation 23
- ATP Synthase and ATPases Research 20
- Cancer Research 121
- MicroRNA in disease regulation 84
- Cancer-related molecular mechanisms research 69
- Co-authors
- Kun Wang (44 shared papers)Rainer Dietz (10 shared papers)Rüdiger von Harsdorf (9 shared papers)Jianxun Wang (30 shared papers)Bo Long (13 shared papers)Man Wang (25 shared papers)Lu‐Yu Zhou (13 shared papers)Cui-Yun Liu (12 shared papers)
- Journals
- Frontiers in Pharmacology (10 papers)Frontiers in Immunology (10 papers)Molecular Therapy — Nucleic Acids (10 papers)Circulation (8 papers)Journal of Cellular and Molecular Medicine (8 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Peifeng Li
389 papers receiving 17.5k citations
Peifeng Li's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 6.8k
- Molecular Biology 11.3k
- Cardiology and Cardiovascular Medicine 1.5k
- Pathology and Forensic Medicine 983
- Aging 94
Countries citing papers authored by Peifeng Li
This map shows the geographic impact of Peifeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peifeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peifeng Li more than expected).
Fields of papers citing papers by Peifeng Li
This network shows the impact of papers produced by Peifeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peifeng Li. The network helps show where Peifeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Peifeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 408 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223 Hit paper breakdown → | 2016 | 738 |
| 2 | miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 Hit paper breakdown → | 2010 | 509 |
| 3 | Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field Hit paper breakdown → | 2020 | 491 |
| 4 | 1999 | 487 | |
| 5 | The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 Hit paper breakdown → | 2014 | 465 |
| 6 | 1999 | 428 | |
| 7 | APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p Hit paper breakdown → | 2015 | 411 |
| 8 | 2014 | 394 | |
| 9 | CRISPR/Cas9 therapeutics: progress and prospects Hit paper breakdown → | 2023 | 388 |
| 10 | Critical role of FOXO3a in carcinogenesis Hit paper breakdown → | 2018 | 362 |
| 11 | NLRP3 inflammasome in endothelial dysfunction Hit paper breakdown → | 2020 | 349 |
| 12 | 2010 | 318 | |
| 13 | 2009 | 288 | |
| 14 | 2017 | 275 | |
| 15 | 1997 | 254 | |
| 16 | 2019 | 249 | |
| 17 | 2015 | 226 | |
| 18 | 2012 | 193 | |
| 19 | 2016 | 171 | |
| 20 | 2008 | 167 |
About Peifeng Li
Peifeng Li is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Materials Chemistry and Surgery, having authored 408 papers that have together received 17.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (84 papers), Circular RNAs in diseases (78 papers), Cancer-related molecular mechanisms research (69 papers), RNA modifications and cancer (40 papers), Mitochondrial Function and Pathology (33 papers), Marine and coastal ecosystems (23 papers), Cell death mechanisms and regulation (23 papers) and ATP Synthase and ATPases Research (20 papers). The work is most often cited by research in Cancer Research (6.8k citations), Molecular Biology (11.3k citations), Cardiology and Cardiovascular Medicine (1.5k citations), Pathology and Forensic Medicine (983 citations) and Aging (94 citations). Peifeng Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Kun Wang, Rainer Dietz, Rüdiger von Harsdorf, Jianxun Wang, Bo Long, Man Wang, Lu‐Yu Zhou, Cui-Yun Liu, Murugavel Ponnusamy and Teng Sun. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Immunology, Molecular Therapy — Nucleic Acids, Circulation and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.